| [1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,65(2):87-108.
|
| [2] |
Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer [J]. Surg Oncol,2006,15(3):153-165.
|
| [3] |
Giuliano AE,McCall L,Beitsch P,et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial[J]. Ann Surg,2010,252(3):426-433.
|
| [4] |
Thompson M, Korourian S, Henry-Tillman R, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation[J]. Ann Surg Oncol,2007,14(6):1890-1895.
|
| [5] |
Sappey PC. Anatomie, Physiologie des vesseaux lymphatiques[M].Paris: Adrien Delahaye,1874:374.
|
| [6] |
Casabona F, Bogliolo S, Valenzano Menada M, et al. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients[J]. Ann Surg Oncol,2009,16(9):2459-2463.
|
| [7] |
Ochoa D, Korourian S, Boneti C, et al. Axillary reverse mapping:five-year experience[J]. Surgery,2014,156(5):1261-1268.
|
| [8] |
Tjalma W, Verbelen H,Gebruers N. The role of an ARM procedure in the prevention of breast cancer related lymphedema[J]. Eur J Surg Oncol,2016,42(1):151-152.
|
| [9] |
Yue T, Zhuang D, Zhou P, et al. A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients[J]. Clin Breast Cancer,2015,15(4):301-306.
|
| [10] |
Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer [J]. J Surg Oncol,2010,101(3):217-221.
|
| [11] |
Noguchi M, Noguchi M, Nakano Y, et al. Axillary reverse mapping using fluorescence imaging system in breast cancer[J]. J Surg Oncol,2012,105(3):229-234.
|
| [12] |
Ikeda K, Ogawa Y, Komatsu H, et al. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients[J]. World J Surg Oncol,2012,10:233-239.
|
| [13] |
Ikeda K, Ogawa Y, Kajino C, et al. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients[J].Eur J Surg Oncol,2014,40(7):818-823.
|
| [14] |
雷睿文,欧林洋,黄湛,等.逆行腋窝淋巴结示踪术对预防乳腺癌术后上肢淋巴水肿的作用[J]. 广东医学,2014,35(5):704-707.
|
| [15] |
Nos C, Kaufmann G, Clough KB, et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection[J]. Ann Surg Oncol,2008,15(9):2550-2555.
|
| [16] |
Ponzone R, Cont NT, Maggiorotto F, et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer[J].J Clin Oncol,2009,27(33):5547-5551.
|
| [17] |
Takashi S, Mariko E, Ken S, et al. Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies[J].J Surg Oncol,2014,109(6):612-615.
|
| [18] |
Clough KB, Nasr R, Nos C,et al. New anatomical classification of the axilla with implications for sentinel node biopsy[J]. Br J Surg,2010,97(11):1659-1665.
|
| [19] |
Nos C, Lesieur B, Clough KB, et al. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection[J]. Ann Surg Oncol,2007,14(9):2490-2496.
|
| [20] |
Pavlista D, Eliska O. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla--a lesson from the past --contribution to the concept of axillary reverse mapping[J]. Eur J Surg Oncol,2012,38(5):390-394.
|
| [21] |
Boneti C,Korourian S,Diaz Z,et al. Scientific impact award:axillary reverse mapping(ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy[J]. Am J Surg,2009,198(4):482-487.
|
| [22] |
Bedrosian I, Babiera GV, Mittendorf EA, et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients[J]. Cancer,2010,116(11):2543-2548.
|
| [23] |
Schunemann E Jr, Dória MT, Silvestre JB,et al. Prospective study evaluating oncological safety of axillary reverse mapping[J]. Ann Surg Oncol,2014,21(7):2197-2202.
|
| [24] |
Beek MA, Gobardhan PD, Klompenhouwer EG, et al. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients[J].Eur J Surg Oncol,2015,41(1):59-63.
|
| [25] |
岳涛,庄大勇,贺青卿,等.腋窝逆向淋巴示踪预防乳腺癌患者上肢淋巴水肿的研究[J/CD]. 中华乳腺病杂志(电子版),2014,8(2):92-98.
|
| [26] |
张明亮,张晓静,田怀杲,等.染料法腋窝反向淋巴作图在早期乳腺癌手术中的应用及分析[J]. 肿瘤防治研究,2014,41(5):452-455.
|
| [27] |
Klompenhouwer EG, Gobardhan PD, Beek MA, et al. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial[J]. Trials,2013,14:111.
|
| [28] |
Rutgers EJ, Donker M, van Tienhoven G. Is there a role for axillary reverse mapping in the current management of breast cancer treatment?[J]. Eur J Surg Oncol,2016,42(1):78.
|
| [29] |
Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer(EORTC 10981-22023 AMAROS): a randomised, multicentre,openlabel,phase 3 non-inferiority trial [J]. Lancet Oncol,2014,15(12):1303-1310.
|
| [30] |
Noguchi M, Miura S, Morioka E,et al. Reply to: ＂Is there a role for axillary reverse mapping in the current management of breast cancer treatment?＂ [J].Eur J Surg Oncol,2016,42(1):153-154.
|
| [31] |
Gebruers N, Verbelen H, De Vrieze T,et al. Incidence and time path of lymphedema in sentinel node negative breast cancer patients: a systematic review [J]. Arch Phys Med Rehabil, 2015, 96 (6):1131-1139.
|